000			01523 a2200349 4500
005			20250517210956.0
264		0	_c20190821
008			201908s 0 0 eng d
022			_a2452-3186
024	7		_a10.1016/j.retram.2018.03.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aChabannon, Christian
245	0	0	_aConsiderations pertaining to cell collection and administration of industry-manufactured autologous CAR-T cells, in relation to French healthcare organization and regulations. _h[electronic resource]
260			_bCurrent research in translational medicine _c05 2018
300			_a59-61 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aCell Separation _xmethods
650	0	4	_aCell- and Tissue-Based Therapy _xmethods
650	0	4	_aClinical Trials as Topic _xlegislation & jurisprudence
650	0	4	_aCommerce
650	0	4	_aDelivery of Health Care _xlegislation & jurisprudence
650	0	4	_aFrance
650	0	4	_aHumans
650	0	4	_aImmunotherapy, Adoptive _xlegislation & jurisprudence
650	0	4	_aLegislation, Medical
650	0	4	_aReceptors, Chimeric Antigen _xtherapeutic use
650	0	4	_aT-Lymphocytes _xtransplantation
650	0	4	_aTissue and Organ Harvesting _xlegislation & jurisprudence
700	1		_aLarghero, Jérôme
773	0		_tCurrent research in translational medicine _gvol. 66 _gno. 2 _gp. 59-61
856	4	0	_uhttps://doi.org/10.1016/j.retram.2018.03.002 _zAvailable from publisher's website
999			_c28258466 _d28258466